For the quarter ending 2025-06-30, NEUE had $27,526K increase in cash & cash equivalents over the period. -$26,528K in free cash flow.
| Cash Flow | 2025-06-30 |
|---|---|
| Share-based compensation | 7,497 |
| Net loss | -12,396 |
| Payment-in-kind pik interest | 8,952 |
| Other, net | -1,029 |
| Unearned revenue | 0 |
| Other assets | -9,567 |
| Medical cost payable | -31,421 |
| Accounts receivable | 16,480 |
| Accounts payable and other liabilities | -12,483 |
| Intangible assets impairment | 0 |
| Gain on troubled debt restructuring | 0 |
| Loss on disposal of property, equipment, and capitalized software | -87 |
| Depreciation and amortization | 7,114 |
| Net accretion of investments | 202 |
| Warrant liability | -2,087 |
| Risk adjustment payable | -4,996 |
| Aco reach performance year receivable | 226,521 |
| Aco reach performance year obligation | 248,465 |
| Net cash used in operating activities | -23,875 |
| Proceeds from sales, paydowns, and maturities of investments | 4,388 |
| Proceeds from sale of business, net | 61,139 |
| Purchases of property and equipment | 2,653 |
| Purchases of investments | 8,224 |
| Net cash provided by investing activities | 54,650 |
| Repayments of short-term borrowings | 1,000 |
| Proceeds from long-term borrowings | 0 |
| Distributions to noncontrolling interest holders | 2,249 |
| Net cash used in financing activities | -3,249 |
| Net increase (decrease) in cash and cash equivalents | 27,526 |
NeueHealth, Inc. (NEUE)
NeueHealth, Inc. (NEUE)